PEOPLES BANCORP INC. COMPLETES ACQUISITION OF CITIZENS NATIONAL CORPORATION _____________________________________________________________________
PEOPLES BANCORP INC (PEBO) filed an SEC Form 8-K — Other Events. P.O. BOX 738 - MARIETTA, OHIO - 45750 NEWS RELEASE www.peoplesbancorp.com FOR IMMEDIATE RELEASE Contact: Tyler J. Wilcox October 30, 2026 President and CEO (740) 373-7737 PEOPLES BANCORP INC. COMPLETES ACQUISITION OF CITIZENS NATIONAL CORPORATION _________________________________
- Role
- acquirer
- Counterparty
- Citizens National Corporation
- Consideration
- mixed
- Deal value
- $646 million in total assets
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The acquisition strengthens Peoples' presence in Eastern Kentucky, likely improving earnings per share and supporting a share‑price rally.
Market read
A material M&A for a mid‑cap regional bank, providing a clear trading catalyst.
What to watch
Potential regulatory scrutiny on the combined loan portfolio and the timing of branch rebranding in 2027.
Background
Peoples Bancorp (Nasdaq: PEBO) completed its April‑announced acquisition of Citizens National Corp., adding 12 Kentucky branches and $646 M in assets.
Ticker impact
Peoples Bancorp Inc. filed an 8‑K announcing the completion of its acquisition of Citizens National Corporation, a material M&A event.
upward pressure as the market prices in the expanded asset base and growth potential
First‑report of a completed acquisition; sizable asset addition for a mid‑cap bank.
Market effects
Regional banking sector may see consolidation pressure; peers could face valuation adjustments.
Mid‑west and Appalachian banking markets may experience modest share‑price re‑rating.
Limited to U.S. regional banking; no direct global impact.
Counterpoint
Integration risks or cultural clashes could delay synergies, weighing on the stock.
Key entities
- companyPeoples Bancorp Inc.
Nasdaq‑listed regional bank acquiring Citizens National.
- companyCitizens National Corporation
Target of the acquisition, previously an OTC‑listed entity.




